Evaluation of human endothelial cells post stent deployment in a cardiovascular simulator in vitro.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 19408120)

Published in Ann Biomed Eng on April 30, 2009

Authors

Marie A Punchard1, Eoin D O'Cearbhaill, Joseph N Mackle, Peter E McHugh, Terry J Smith, Catherine Stenson-Cox, Valerie Barron

Author Affiliations

1: National Centre for Biomedical Engineering, Orbsen Building, National University of Ireland, Galway, University Road, Galway, Ireland.

Articles by these authors

Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology (2009) 2.44

Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev (2003) 2.23

Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2009) 2.10

Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol (2003) 1.75

T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology (2005) 1.58

Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol (2003) 1.51

Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol (2008) 1.45

Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes. Eur J Immunol (2002) 1.36

Improved detection of DNA motifs using a self-organized clustering of familial binding profiles. Bioinformatics (2005) 1.29

Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol (2002) 1.26

Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med (2005) 1.24

Integrated microfluidic tmRNA purification and real-time NASBA device for molecular diagnostics. Lab Chip (2008) 1.22

More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest (2006) 1.21

Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol (2007) 1.20

IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol (2005) 1.18

Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. J Biol Chem (2002) 1.15

Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol (2002) 1.14

Carbon nanotubes and mesenchymal stem cells: biocompatibility, proliferation and differentiation. Nano Lett (2008) 1.11

Transcription factor binding site identification using the self-organizing map. Bioinformatics (2005) 1.11

Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophthalmol (2010) 1.11

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci (2008) 1.10

Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab (2012) 1.08

Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J Immunol (2006) 1.07

Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proc Natl Acad Sci U S A (2013) 1.07

A bio-inspired swellable microneedle adhesive for mechanical interlocking with tissue. Nat Commun (2013) 1.06

Immune mechanisms in thyroid eye disease. Thyroid (2008) 1.05

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab. Clin Endocrinol (Oxf) (2011) 1.04

Inhibitory effect of leptin on human uterine contractility in vitro. Am J Obstet Gynecol (2006) 1.04

The electrical stimulation of carbon nanotubes to provide a cardiomimetic cue to MSCs. Biomaterials (2012) 1.04

Modulation of human uterine smooth muscle cell collagen contractility by thrombin, Y-27632, TNF alpha and indomethacin. Reprod Biol Endocrinol (2009) 1.03

Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03

A blood-resistant surgical glue for minimally invasive repair of vessels and heart defects. Sci Transl Med (2014) 1.02

Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid (2008) 0.99

Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci U S A (2012) 0.97

B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J Immunol (2008) 0.96

Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. J Immunol (2004) 0.96

Fabrication, mechanical and in vivo performance of polycaprolactone/tricalcium phosphate composite scaffolds. Acta Biomater (2012) 0.96

Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. J Biol Chem (2006) 0.95

Treating the thyroid in the presence of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab (2012) 0.94

Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Invest Ophthalmol Vis Sci (2012) 0.94

Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression. Am J Physiol Cell Physiol (2003) 0.94

PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One (2010) 0.93

Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol (2011) 0.93

Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions. PLoS One (2013) 0.92

Response of mesenchymal stem cells to the biomechanical environment of the endothelium on a flexible tubular silicone substrate. Biomaterials (2008) 0.92

Heterogeneous linear elastic trabecular bone modelling using micro-CT attenuation data and experimentally measured heterogeneous tissue properties. J Biomech (2008) 0.91

Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease. J Biol Chem (2011) 0.91

Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab (2014) 0.90

Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology (2006) 0.88

Rosiglitazone-induced proptosis. Arch Ophthalmol (2005) 0.88

Analysis of Maxi-K alpha subunit splice variants in human myometrium. Reprod Biol Endocrinol (2004) 0.88

Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor. J Soc Gynecol Investig (2005) 0.87

Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use. J Nanobiotechnology (2010) 0.87

Expression of prothrombin and protease activated receptors in human myometrium during pregnancy and labor. Biol Reprod (2007) 0.87

Molecular cloning of an IL-8-like CXC chemokine and tissue factor in rainbow trout (Oncorhynchus mykiss) by use of suppression subtractive hybridization. Cytokine (2002) 0.86

Uterine contractility of plants used to facilitate childbirth in Nigerian ethnomedicine. J Ethnopharmacol (2012) 0.86

Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes. J Clin Endocrinol Metab (2005) 0.86

Human chorionic gonadotrophin relaxation of human pregnant myometrium and activation of the BKCa channel. J Clin Endocrinol Metab (2003) 0.86

Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma. J Immunol (2005) 0.86

Quantitative surface-enhanced Raman spectroscopy of dipicolinic acid--towards rapid anthrax endospore detection. Analyst (2005) 0.86

The effect of physiological cyclic stretch on the cell morphology, cell orientation and protein expression of endothelial cells. J Mater Sci Mater Med (2007) 0.85

Testes and brain gene expression in precocious male and adult maturing Atlantic salmon (Salmo salar). BMC Genomics (2010) 0.85

In vitro characterization of an electroactive carbon-nanotube-based nanofiber scaffold for tissue engineering. Macromol Biosci (2011) 0.85

Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy. Thyroid (2008) 0.85

Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation. J Clin Endocrinol Metab (2013) 0.85

Cellular longevity: role of apoptosis and replicative senescence. Biogerontology (2002) 0.85

Acute phase gene expression in rainbow trout (Oncorhynchus mykiss) after exposure to a confinement stressor: A comparison of pooled and individual data. Fish Shellfish Immunol (2009) 0.85

Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB, and RGS12 gene expression in human myometrium at labor. Reprod Sci (2008) 0.84

Characterization of the anaemia associated with Graves' disease. Clin Endocrinol (Oxf) (2008) 0.84

Enhancing the mesenchymal stem cell therapeutic response: cell localization and support for cartilage repair. Tissue Eng Part B Rev (2012) 0.84

Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. J Clin Endocrinol Metab (2014) 0.84

Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy? Nat Rev Endocrinol (2011) 0.83

Isolation and characterization of the bovine Stearoyl-CoAdesaturase promoter and analysis of polymorphisms in the promoter region in dairy cows. Mamm Genome (2005) 0.83

Comparison of trabecular bone behavior in core and whole bone samples using high-resolution modeling of a vertebral body. Biomech Model Mechanobiol (2010) 0.83

tmRNA--a novel high-copy-number RNA diagnostic target--its application for Staphylococcus aureus detection using real-time NASBA. FEMS Microbiol Lett (2009) 0.83

Differential expression of the metalloproteinase MMP3 and the alpha5 integrin subunit in human myometrium at labour. Mol Hum Reprod (2007) 0.83

Expression of RHOGTPase regulators in human myometrium. Reprod Biol Endocrinol (2008) 0.82

B cell depletion in Graves' disease: the right answer to the wrong question? J Clin Endocrinol Metab (2007) 0.82

Is IGF-I receptor a target for autoantibody generation in Graves' disease? J Clin Endocrinol Metab (2013) 0.82

Human coronary artery smooth muscle cell response to a novel PLA textile/fibrin gel composite scaffold. Acta Biomater (2008) 0.82

Cloning and characterization of two genes encoding rainbow trout homologues of the IFITM protein family. Vet Immunol Immunopathol (2006) 0.82

Behavior of human mesenchymal stem cells in fibrin-based vascular tissue engineering constructs. Ann Biomed Eng (2010) 0.82

Gene prediction using the Self-Organizing Map: automatic generation of multiple gene models. BMC Bioinformatics (2004) 0.82

Rapid detection of Listeria monocytogenes in food using culture enrichment combined with real-time PCR. Food Microbiol (2008) 0.82

Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases. J Clin Endocrinol Metab (2014) 0.81

Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology (2006) 0.81

Self-organizing neural networks to support the discovery of DNA-binding motifs. Neural Netw (2006) 0.81

Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes (2008) 0.81

Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17. PLoS One (2012) 0.81

Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts. J Clin Endocrinol Metab (2014) 0.80

OxLDL-induced gene expression patterns in CASMC are mimicked in apoE-/- mice aortas. Biochem Biophys Res Commun (2007) 0.80

HUVEC ICAM-1 and VCAM-1 synthesis in response to potentially athero-prone and athero-protective mechanical and nicotine chemical stimuli. Ann Biomed Eng (2010) 0.80

Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique. Arch Ophthalmol (2009) 0.79

Failure modelling of trabecular bone using a non-linear combined damage and fracture voxel finite element approach. Biomech Model Mechanobiol (2012) 0.79

Molecular cloning and expression analysis of rainbow trout (Oncorhynchus mykiss) matrix metalloproteinase-9. Fish Shellfish Immunol (2004) 0.79

Hypoxia and ischemia induce nuclear condensation and caspase activation in cardiomyocytes. Ann N Y Acad Sci (2003) 0.79